Rare disease communities exploit venture philanthropy to drive healthcare innovations with impact at a global level. Patient groups now need to engage better with fellow investors to improve this healthcare model. To solve current challenges and barriers participants will be asked to share experiences to help answer the following questions. How do we position investment in rare disease innovation as a worthwhile risk? What are investor expectations on impact measurement and how are they met? Are complexity and timescales barriers to collaborative philanthropy? Can expert hubs or toolkits make investment more efficient?
06-11-2019 10:30 - 12:30Hosted by: Ritchie Head
Messages will be visible for table members and will NOT be shared on Facebook.